Colwell John A
Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
Nat Rev Endocrinol. 2009 Apr;5(4):188-90. doi: 10.1038/nrendo.2009.44.
The use of aspirin for the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus is controversial. According to the findings of a Japanese trial, aspirin does not reduce the risk of cardiovascular events in this group of patients, unless they are aged 65 years and above.
阿司匹林用于2型糖尿病患者心血管事件的一级预防存在争议。根据一项日本试验的结果,阿司匹林并不能降低这类患者发生心血管事件的风险,除非他们年龄在65岁及以上。